This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and ill-defined digestive organs (controls excluding all cancers)
C3_DIGESTIVE_ORGANS_NAS_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
160
Control definitions
Extra metadata
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to Malignant neoplasm of other and ill-defined digestive organs (controls excluding all cancers) based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of other and ill-defined digestive organs
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 160 | 70 | 90 |
Unadjusted prevalence (%) | 0.04 | 0.03 | 0.05 |
Mean age at first event (years) | 72.31 | 71.89 | 72.63 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_DIGESTIVE_ORGANS_NAS_EXALLC – Malignant neoplasm of other and ill-defined digestive organs (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of other and ill-defined digestive organs (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.